Neurotar presents at the 8th Swiss-Scandinavian Bio-Business Seminar in Zurich on February 12, 2014

This year, Neurotar will feature its proprietary research devices and the new types of research that they enable.  Katja Karelina (CEO) and Leonard Khiroug (CSO) are happy to talk to investors about our plans to grow the company, and to partners interested in advancing their biologics’ development through in vivo two-photon imaging –based screening.  We shall linger in the area – please contact us to schedule meetings outside of the seminar.